Immunogenicity and Safety of Varicella Vaccine, Live in Healthy Children Aged 12~15 Months in the Philippines
Clinical trial NCT06314724 · COMPLETED
Trial details
- NCT number
- NCT06314724
- Sponsor
- Sinovac (Dalian) Vaccine Technology Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-29
- Primary completion
- 2024-09-06
- Enrollment
- 642
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.